BioCryst Shatters Revenue Guidance with ORLADEYO—2025 Net Sales Up 37%, 2026 Outlook Remains Strong
Market Chameleon (Mon, 12-Jan 7:54 AM)
FDA Approves BioCryst's ORLADEYO Oral Pellets: Transforming HAE Care for Young Children
Market Chameleon (Fri, 12-Dec 7:52 AM)
BioCryst Achieves Key Antitrust Milestone as Astria Acquisition Moves Closer to Completion
Market Chameleon (Thu, 4-Dec 11:16 AM)
